Optogenetics' promise: pacing and cardioversion by light?
作者信息
Ambrosi Christina M, Entcheva Emilia
机构信息
Department of Biomedical Engineering, Stony Brook University, BST6-120B, Stony Brook, NY 11794-8661, USA.
出版信息
Future Cardiol. 2014 Jan;10(1):1-4. doi: 10.2217/fca.13.89.
Abstract
摘要
相似文献
1
Optogenetics' promise: pacing and cardioversion by light?光遗传学的前景：用光进行起搏和心脏复律？
Future Cardiol. 2014 Jan;10(1):1-4. doi: 10.2217/fca.13.89.
2
Electrical therapy of arrhythmias.心律失常的电疗法。
Cardiol Clin. 1985 Nov;3(4):617-22.
3
[Possibilities of electrotherapy of the heart in the prehospital phase].[院前阶段心脏电疗法的可能性]
Z Arztl Fortbild (Jena). 1984;78(15):623-5.
4
Non-classical indications for cardiac resynchronization therapy.心脏再同步治疗的非经典适应证
Hellenic J Cardiol. 2009 May-Jun;50(3):208-15.
5
Cardiac resynchronization therapy--who benefits? Separating myths from facts.心脏再同步治疗——谁能从中获益？分清假象与事实。
Indian Heart J. 2007 Jan-Feb;59(1 Suppl A):A57-62.
6
Application of new pacemaker and defibrillator technology.新型起搏器和除颤器技术的应用。
Adv Card Surg. 1994;5:181-208.
7
Current state of the art for use of pacemakers and defibrillators in patients with congenital cardiac malformations.先天性心脏畸形患者使用起搏器和除颤器的当前技术水平。
Cardiol Young. 2006 Sep;16 Suppl 3:151-6. doi: 10.1017/s1047951106001090.
8
European Resuscitation Council Guidelines for Resuscitation 2010 Section 3. Electrical therapies: automated external defibrillators, defibrillation, cardioversion and pacing.《2010年欧洲复苏委员会复苏指南》第3节。电疗法：自动体外除颤器、除颤、心脏复律和起搏。
Resuscitation. 2010 Oct;81(10):1293-304. doi: 10.1016/j.resuscitation.2010.08.008.
9
[Cardiac resynchronization therapy: are all questions answered?].[心脏再同步治疗：所有问题都得到解答了吗？]
Herzschrittmacherther Elektrophysiol. 2005 Mar;16(1):1-2. doi: 10.1007/s00399-005-0454-0.
10
[Non-pharmacologic treatment of cardiac arrhythmias].[心律失常的非药物治疗]
Rev Med Brux. 1988 Jan-Feb;9(1):4-12.
引用本文的文献
1
Cardiac optogenetics: shining light on signaling pathways.心脏光遗传学：照亮信号通路。
Pflugers Arch. 2023 Dec;475(12):1421-1437. doi: 10.1007/s00424-023-02892-y. Epub 2023 Dec 14.
2
Optogenetics for light control of biological systems.用于生物系统光控的光遗传学
Nat Rev Methods Primers. 2022;2. doi: 10.1038/s43586-022-00136-4. Epub 2022 Jul 21.
3
Optogenetic Stimulation Using Anion Channelrhodopsin (GtACR1) Facilitates Termination of Reentrant Arrhythmias With Low Light Energy Requirements: A Computational Study.使用阴离子通道视紫红质（GtACR1）的光遗传学刺激以低光能量需求促进折返性心律失常的终止：一项计算研究。
Front Physiol. 2021 Aug 30;12:718622. doi: 10.3389/fphys.2021.718622. eCollection 2021.
4
Cardiac optogenetics: a decade of enlightenment.心脏光遗传学：十年的启示。
Nat Rev Cardiol. 2021 May;18(5):349-367. doi: 10.1038/s41569-020-00478-0. Epub 2020 Dec 18.
5
Cardiac Optogenetics in Atrial Fibrillation: Current Challenges and Future Opportunities.心脏光遗传学在心房颤动中的应用：当前挑战与未来机遇
Biomed Res Int. 2020 Oct 27;2020:8814092. doi: 10.1155/2020/8814092. eCollection 2020.
6
Non-invasive red-light optogenetic control of Drosophila cardiac function.非侵入式红光光遗传学调控果蝇心脏功能。
Commun Biol. 2020 Jun 29;3(1):336. doi: 10.1038/s42003-020-1065-3.
7
Optogenetics: Background, Methodological Advances and Potential Applications for Cardiovascular Research and Medicine.光遗传学：心血管研究与医学的背景、方法学进展及潜在应用
Front Bioeng Biotechnol. 2020 Jan 29;7:466. doi: 10.3389/fbioe.2019.00466. eCollection 2019.
8
Energy-Reduced Arrhythmia Termination Using Global Photostimulation in Optogenetic Murine Hearts.在光遗传学小鼠心脏中使用全局光刺激降低能量的心律失常终止
Front Physiol. 2018 Nov 27;9:1651. doi: 10.3389/fphys.2018.01651. eCollection 2018.
9
Termination of re-entrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting: insights from computational models.经优化空间靶向的光遗传学刺激终止折返性房性心动过速：计算模型的见解。
J Physiol. 2018 Jan 15;596(2):181-196. doi: 10.1113/JP275264. Epub 2017 Dec 28.
10
Anion channelrhodopsins for inhibitory cardiac optogenetics.阴离子通道视蛋白在抑制性心脏光遗传学中的应用。
Sci Rep. 2016 Sep 15;6:33530. doi: 10.1038/srep33530.
本文引用的文献
1
Computational optogenetics: empirically-derived voltage- and light-sensitive channelrhodopsin-2 model.计算光遗传学：基于经验的电压和光敏感通道视紫红质-2 模型。
PLoS Comput Biol. 2013;9(9):e1003220. doi: 10.1371/journal.pcbi.1003220. Epub 2013 Sep 12.
2
Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them.腺相关病毒 (AAV) 载体在基因治疗中的应用：免疫挑战及规避策略。
Rev Med Virol. 2013 Nov;23(6):399-413. doi: 10.1002/rmv.1762. Epub 2013 Sep 10.
3
ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation.ReaChR：一种红色偏移的通道视紫红质变体，可实现深颅穿透光遗传学激发。
Nat Neurosci. 2013 Oct;16(10):1499-508. doi: 10.1038/nn.3502. Epub 2013 Sep 1.
4
A comprehensive multiscale framework for simulating optogenetics in the heart.用于模拟心脏中的光遗传学的综合多尺度框架。
Nat Commun. 2013;4:2370. doi: 10.1038/ncomms3370.
5
Injectable, cellular-scale optoelectronics with applications for wireless optogenetics.可注射的细胞级光电设备，适用于无线光遗传学。
Science. 2013 Apr 12;340(6129):211-6. doi: 10.1126/science.1232437.
6
Cardiac optogenetics.心脏光遗传学。
Am J Physiol Heart Circ Physiol. 2013 May;304(9):H1179-91. doi: 10.1152/ajpheart.00432.2012. Epub 2013 Mar 1.
7
On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy.按需光遗传学控制颞叶癫痫的自发性癫痫发作。
Nat Commun. 2013;4:1376. doi: 10.1038/ncomms2376.
8
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.冠状动脉心脏球源性细胞治疗心肌梗死后的心脏再生（CADUCEUS）：一项前瞻性、随机 1 期试验。
Lancet. 2012 Mar 10;379(9819):895-904. doi: 10.1016/S0140-6736(12)60195-0. Epub 2012 Feb 14.
9
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.缺血性心肌病患者的心脏干细胞（SCIPIO）：一项随机 1 期试验的初步结果。
Lancet. 2011 Nov 26;378(9806):1847-57. doi: 10.1016/S0140-6736(11)61590-0. Epub 2011 Nov 14.
10
Development of viral vectors for use in cardiovascular gene therapy.用于心血管基因治疗的病毒载体的开发。
Viruses. 2010 Feb;2(2):334-371. doi: 10.3390/v2020334. Epub 2010 Jan 27.
Zotero 插件